Virios Therapeutics | DEFA14A: Others
Virios Therapeutics | 8-K: Current report
Virios Therapeutics | 10-Q: Q2 2024 Earnings Report
Virios Therapeutics | 8-K: Virios Therapeutics Announces Second Quarter 2024 Financial Results
Virios Therapeutics | 8-K: Current report
Virios Therapeutics | 8-K: Current report
Virios Therapeutics | 424B4: Prospectus
Virios Therapeutics | 8-K: Current report
Virios Therapeutics | 424B4: Prospectus
Virios Therapeutics | 10-Q: Q1 2024 Earnings Report
Virios Therapeutics | 8-K: Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Virios Therapeutics | 8-K: Current report
Virios Therapeutics | ARS: Annual Report to Security Holders
Virios Therapeutics | DEF 14A: Definitive information statements
Virios Therapeutics | 10-K/A: Annual report (Amendment)
Virios Therapeutics | 8-K: Current report
Virios Therapeutics | 10-K: FY2023 Annual Report
Virios Therapeutics | 8-K: Virios Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pridgen William
Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thomas John C
No Data
No Data